SCG is the key connector for Oxford and AstraZeneca COVID-19 Vaccine distribution throughout South East Asia
On May 4 2022, the Vice Chancellor, Professor Louise Richardson, and Sir John Bell welcomed SCGC Chemicals Public Co., Ltd to Oxford University, to acknowledge their contribution to the Oxford-Astra Zeneca vaccination programme in Asia
SCG is the key connector for Oxford and AstraZeneca COVID-19 Vaccine distribution throughout South East Asia
SCG has signed an agreement with AstraZeneca and others for the manufacture and distribution of Oxford’s ChAdOx1 nCov-2019 coronavirus vaccine in South-East Asia.
On 12 October 2020, the Thai Ministry of Public Health, AstraZeneca, Siam Bioscience and SCG agreed to work together to prepare the large-scale manufacture and supply of Oxford’s potential COVID-19 vaccine for supply in South East Asia. The result is a partnership between SCG, the Government of Thailand, AstraZeneca and Siam Bioscience to manufacture the Oxford COVID-19 vaccine in Thailand for potential distribution across South-East Asia.
Find out more about SCG's contribution to AstraZeneca COVID-19 Vaccine distribution throughout South East Asia
- Agreement signed to aid manufacture and distribution of vaccine in South-East Asia | Research | University of Oxford
- Thailand joins forces with AstraZeneca on COVID-19 vaccine manufacturing - GOV.UK (www.gov.uk)
